General Announcement::Proceedings and Scrutinizer s Report of the 41st Annual General Meeting (AGM)

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
27-Sep-2019 23:18:03
Status
New
Announcement Sub Title
Proceedings and Scrutinizer s Report of the 41st Annual General Meeting (AGM)
Announcement Reference
SG190927OTHR000Y
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd
Designation
Company Secretary & Compliance Office
Effective Date and Time of the event
27/09/2019 17:00:00
Description (Please provide a detailed description of the event in the box below)
The 41st AGM of the Company was held on Friday, September 27, 2019 at 11.00 a.m. at Sunville Banquets & Conference Hall, 3rd floor, Dr. Annie Besant Road, Worli, Mumbai - 400 018 to transact the business as stated in the notice dated May 29, 2019, convening the AGM.

In this regard, please find enclosed the following:

1. Summary of the proceedings of the AGM of the Company as required under Regulation 30, Para A of Schedule - III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. ( Listing Regulations ) - Annexure A.
2. Voting results of the business transacted at the AGM, as required under Regulation 44 (3) of the Listing Regulations has been filed in XBRL Mode.
3. Report of the Scrutinizer pursuant to Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 of today s date - Annexure B. The Scrutinizer s Report of today s date is made available on the Company s website at www.glenmarkpharma.com

This is for your Information and records.

Attachments

SGX_AGM_OUTCOME_27092019.pdf
Total size =5501K